COCHW
Envoy Medical, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- X Aug 14 Short interest jumps 40.1% to 77.6K
- X Sep 15 Short interest falls 54.3% to 32.3K
- X Sep 30 Short interest falls 93.3% to 2.2K
- E Oct 23 Trading halt: Trading Halt: COCHW — T1 (News Pending)
- E Oct 23 Trading halt: Trading Halt: COCHW — T3 (News and Resumption Times)
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q4 2025: 0 added (0 new), 1 trimmed or exited.
- TrendDOWNTREND
6% below its 50-day average.
Who's buying
13F· Q4 2025| Fund | Move | Value |
|---|---|---|
| Clear Street Group Inc. | TRIM | $11.7K |
| Walleye Trading LLC | TRIM | $5.8K |
| Walleye Trading LLC | TRIM | $9.6K |
| Walleye Trading LLC | ADD | $24.9K |
| Man Group plc | TRIM | $8.9K |
| Walleye Capital LLC | NEAR_EXIT | $1.5K |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $85.0K |
| Next Q | — | — | — | $85.0K |
| Current FY | — | — | — | $233.3K |
| Next FY | — | — | — | $273.3K |
Short side
FINRA· Oct 15, 2026| Oct 23, 2026 | Resumption Scheduled | Resumed |
SecBot reports
4 filings · 0 bullish · 0 bearish · 1 mixed · 3 neutral- NEUTRAL 8-KMay 18, 2026
Envoy Medical reported results from its 2026 Annual Meeting held May 12, 2026. Stockholders…
This is a routine annual meeting governance filing with no financial data, guidance, or operational catalysts. The additional share authorizations enable future equity grants and ESPP purchases but…
- MIXED 8-KMay 11, 2026
Envoy Medical reported Q1 2026 revenue of $39K, down 15% YoY, with an operating loss of $5.96M…
The clinical and financing milestones reduce near-term dilution risk. Next catalyst: PMA submission to FDA following 12-month data collection. Monitor for data readouts and regulatory updates.
- NEUTRAL 3Apr 17, 2026
Chas McKhann, a Section 16 officer, filed a Form 3 to report initial beneficial ownership of Envoy…
No material ownership or transaction data was disclosed; this is a standard administrative filing. Traders should monitor future Forms 4 for any actual insider buying or selling activity.
- NEUTRAL 10-K/AApr 13, 2026
Envoy Medical filed an amended 10-K/A solely to correct a typographical error in Grant Thornton…
This is a routine administrative filing with no fundamental impact on the company's financials or operations. Traders should note the recent auditor change as a potential point of scrutiny, but this…
All COCHW filing & press-release reports (4)
- 8-K reportMay 18, 2026
- 8-K reportMay 11, 2026
- 3 reportApr 17, 2026
- 10-K/A reportApr 13, 2026